Allogeneic umbilical cord mesenchymal stem cell
transplantation for metabolic syndrome in a tree shrew model

doi:10.3969/j.issn.2095-4344.1861

Chinese Journal of Tissue Engineering Research ›› 2020, Vol. 24 ›› Issue (1): 51-58.doi: 10.3969/j.issn.2095-4344.1861

Allogeneic umbilical cord mesenchymal stem cell transplantation for metabolic syndrome in a tree shrew model

Ruan Guangping^{1, 2, 3}, Yao Xiang^{1, 2, 3}, Cai Xuemin^{1, 2,
3}, Li Zian^{1, 2, 3}, Pang Rongqing^{1, 2, 3}, Pan Xinghua^{1, 2, 3}

¹The Cell Biological Therapy Center of 920^th Hospital of Joint Logistics Support Force of PLA, Kunming 650032, Yunnan Province, China; ²The Integrated Engineering Laboratory of Cell Biological Medicine of State and Regions, Kunming 650032, Yunnan Province, China; ³The Transfer Medicine Key Laboratory of Cell Therapy Technology of Yunan Province, Kunming 650032, Yunnan Province, China

Received:2019-03-13 Revised:2019-03-21 Accepted:2019-04-19 Online:2020-01-08 Published:2019-12-11
Contact: Pan Xinghua, MD, Chief physician, The Cell Biological Therapy Center of 920th Hospital of Joint Logistics Support Force of PLA, Kunming 650032, Yunnan Province, China; The Integrated Engineering Laboratory of Cell Biological Medicine of State and Regions, Kunming 650032, Yunnan Province, China; The Transfer Medicine Key Laboratory of Cell Therapy Technology of Yunan Province, Kunming 650032, Yunnan Province, China
About author:Ruan Guangping, MD, Associate chief physician, The Cell Biological Therapy Center of 920th Hospital of Joint Logistics Support Force of PLA, Kunming 650032, Yunnan Province, China; The Integrated Engineering Laboratory of Cell Biological Medicine of State and Regions, Kunming 650032, Yunnan Province, China; The Transfer Medicine Key Laboratory of Cell Therapy Technology of Yunan Province, Kunming 650032, Yunnan Province, China
Supported by:
the Major Science and Technology Project of Yunnan Science and Technology Plan Project, No. 2018ZF007; Yunnan Province Key Projects, No. 2018FA041, 2017FA040, and 2015FA039

Abstract

Abstract:

BACKGROUND: Current treatments for metabolic syndrome are comprehensive treatments with drugs, aiming to improve patient’s life. Patients are required to have a high compliance to follow-up and have developed various adverse reactions. Therefore, there is no treatment to fundamentally delay the development of metabolic syndrome.

OBJECTIVE: To establish a tree shrew model of metabolic syndrome and evaluation techniques, and to explore the therapeutic effect of umbilical cord mesenchymal stem cells in the tree shrew model, providing theoretical basis and reference method for clinical application of stem cell transplantation in metabolic syndromes.

METHODS: Umbilical cord mesenchymal stem cells of tree shrews were obtained by adherent culture method, and met the biological characteristics of umbilical cord mesenchymal stem cells. The dark red fluorescent iodide DIR was used to label tree umbilical cord mesenchymal stem cells. Thirty-two tree shrews were fed high-sugar, high-cholesterol, high-salt diet and syrup diet, and injected streptozotocin to make metabolic syndrome models. Animal models were randomly divided into model control group (n=10) and cell treatment group (n=22). In the cell treatment group, the umbilical cord mesenchymal stem cells labeled in vitro were injected into the tail vein, and the model group was injected an equal volume of physiological saline in the meanwhile. Blood biochemical indicators, glucose tolerance, insulin resistance index and arterial blood pressure were measured after transplantation.

RESULTS AND CONCLUSION: The tree shrew model of metabolic syndrome was successfully constructed, showing obvious insulin resistance, hyperglycemia, lipid metabolism disorder, and hypertension, which met the diagnostic criteria of metabolic syndrome. Umbilical cord mesenchymal stem cells transplantation could significantly reduce the blood glucose and blood lipid levels, improve insulin resistance and regulate insulin secretion in the tree shrew model of metabolic syndrome. Transplanted umbilical cord mesenchymal stem cells could be homing to the liver, kidney and pancreas of the tree shrew model of metabolic syndrome, and produce certain repairing effects.

Key words: metabolic syndrome, umbilical cord mesenchymal stem cells, tree shrew, cell transplantation, blood glucose, insulin, insulin resistance

CLC Number:

Ruan Guangping, Yao Xiang, Cai Xuemin, Li Zian, Pang Rongqing, Pan Xinghua. Allogeneic umbilical cord mesenchymal stem cell transplantation for metabolic syndrome in a tree shrew model[J]. Chinese Journal of Tissue Engineering Research, 2020, 24(1): 51-58.

Figures/Tables 9

References

[1] REAVEN GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595-1607.
[2] ZHANG Y, SHEN W, HUA J, et al. Pancreatic islet-like clusters from bone marrow mesenchymal stem cells of human first-trimester abortus can cure streptozocin-induced mouse diabetes. Rejuvenation Res. 2010; 13(6):695-706.
[3] WEN Y, CHEN B, ILDSTAD ST. Stem cell-based strategies for the treatment of type 1 diabetes mellitus. Expert Opin Biol Ther. 2011;11(1): 41-53.
[4] 刘静,赵冬,刘军,等. 代谢综合征与自由脂肪酸的关系[J]. 中华心血管病杂志, 2005,33(7):653-657.
[5] 岳松,田凤石.代谢综合征的诊断标准和防治研究进展[J]. 天津医药, 2011, 39(8):770-773.
[6] PROWSE AB, CHONG F, GRAY PP, et al. Stem cell integrins: implications for ex-vivo culture and cellular therapies. Stem Cell Res. 2011;6(1):1-12.
[7] REYES M, DUDEK A, JAHAGIRDAR B, et al. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest. 2002; 109(3):337-346.
[8] 阮光萍,朱路,刘菊芬,等. 树鼩脐带间充质干细胞分离、培养及成骨成脂分化的鉴定[J].中国组织工程研究, 2017,21(9):1373-1377.
[9] 周晖,高彦彬,罗文益,等. 中西医结合治疗Ⅱ型糖尿病合并代谢综合征病例回顾研究[J].中国民族民间医药,2009,18(1):73-75.
[10] ZHU H, SONG X, JIN LJ, et al. Comparison of intra-coronary cell transplantation after myocardial infarction: Autologous skeletal myoblasts versus bone marrow mesenchymal stem cells. J Int Med Res. 2009;37(2):298-307.
[11] CHEN B, QIN MC, HUANG JL, et al. Preliminary establishment of integration of Alzheimer's disease and blood stasis syndrome tree shrew model and evaluation of intervention of Panax notoginseng saponins. Zhongguo Zhong Yao Za Zhi. 2017;42(6):1175-1182.
[12] JIANG LP, SHEN QS, YANG CP, et al. Establishment of basal cell carcinoma animal model in Chinese tree shrew (Tupaia belangeri chinensis). Zool Res. 2017;38(4):180-190.
[13] FENG Y, FENG YM, LU C, et al. Tree shrew, a potential animal model for hepatitis C, supports the infection and replication of HCV in vitro and in vivo. J Gen Virol. 2017;98(8):2069-2078.
[14] XIAO J, LIU R, CHEN CS. Tree shrew (Tupaia belangeri) as a novel laboratory disease animal model. Zool Res. 2017;38(3):127-137.
[15] TONG Y, HAO J, TU Q, et al. A tree shrew glioblastoma model recapitulates features of human glioblastoma. Oncotarget. 2017;8(11): 17897-17907.
[16] FAN Y, LUO R, SU LY, et al. Does the Genetic Feature of the Chinese Tree Shrew (Tupaia belangeri chinensis) Support Its Potential as a Viable Model for Alzheimer's Disease Research. J Alzheimers Dis. 2018;61(3):1015-1028.
[17] LI R, YUAN B, XIA X, et al. Tree shrew as a new animal model to study the pathogenesis of avian influenza (H9N2) virus infection. Emerg Microbes Infect. 2018;7(1):166.
[18] LI R, ZANIN M, XIA X, et al. The tree shrew as a model for infectious diseases research. J Thorac Dis. 2018;10(Suppl 19):S2272-S2279.
[19] SAMUELS BC, SIEGWART JT, ZHAN W, et al. A Novel Tree Shrew (Tupaia belangeri) Model of Glaucoma. Invest Ophthalmol Vis Sci. 2018;59(7): 3136-3143.
[20] ZHENG H, NIU S, ZHAO H, et al. Donepezil improves the cognitive impairment in a tree shrew model of Alzheimer's disease induced by amyloid-β1-40 via activating the BDNF/TrkB signal pathway. Metab Brain Dis. 2018;33(6):1961-1974.
[21] WU KH, YANG SG, ZHOU B, et al. Human umbilical cord derived stem cells for the injured heart. Med Hypotheses. 2007;68(1):94-97.
[22] LIEW CG, ANDREWS PW. Stem cell therapy to treat diabetes mellitus. Rev Diabet Stud. 2008;5(4):203-219.
[23] XIN L, LIN X, PAN Y, et al. A collagen scaffold loaded with human umbilical cord-derived mesenchymal stem cells facilitates endometrial regeneration and restores fertility. Acta Biomater. 2019 May 7. doi: 10.1016/j.actbio.2019.05.012.[Epub ahead of print]
[24] BOUGIOUKLI S, SAITTA B, SUGIYAMA O, et al. Lentiviral Gene Therapy for Bone Repair Using Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells. Hum Gene Ther. 2019 Apr 22. doi: 10.1089/hum.2018.054. [Epub ahead of print]
[25] PARK YB, HA CW, KIM JA, et al. Comparison of Undifferentiated Versus Chondrogenic Predifferentiated Mesenchymal Stem Cells Derived From Human Umbilical Cord Blood for Cartilage Repair in a Rat Model. Am J Sports Med. 2019;47(2):451-461.
[26] WU X, XU L, SHEN Y, et al. MALP-2, an agonist of TLR6, promotes the immune status without affecting the differentiation capacity of umbilical cord mesenchymal stem cells. Exp Ther Med. 2017;14(6): 5540-5546.
[27] MAIA L, DE MORAES CN, DIAS MC, et al. A proteomic study of mesenchymal stem cells from equine umbilical cord. Theriogenology. 2017;100:8-15.
[28] YANG Y, WANG Y, LI L, et al. Activation of the Toll-like receptor 8 pathway increases the immunogenicity of mesenchymal stem cells from umbilical cord. Mol Med Rep. 2017;16(2):2061-2068.
[29] ASGARI HR, AKBARI M, YAZDEKHASTI H, et al. Comparison of Human Amniotic, Chorionic, and Umbilical Cord Multipotent Mesenchymal Stem Cells Regarding Their Capacity for Differentiation Toward Female Germ Cells. Cell Reprogram. 2017;19(1):44-53.
[30] GAO X, SONG L, SHEN K, et al. Transplantation of bone marrow derived cells promotes pancreatic islet repair in diabetic mice. Biochem Biophys Res Commun. 2008;371(1):132-137.

Allogeneic umbilical cord mesenchymal stem cell transplantation for metabolic syndrome in a tree shrew model

PDF

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 9

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Chen Ziyang, Pu Rui, Deng Shuang, Yuan Lingyan. Regulatory effect of exosomes on exercise-mediated insulin resistance diseases [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(25): 4089-4094.
[2]	Ruan Guangping, Yao Xiang, Liu-Gao Miyang, Cai Xuemin, Li Zian, Pang Rongqing, Wang Jinxiang, Pan Xinghua. Umbilical cord mesenchymal stem cell transplantation for traumatic systemic inflammatory response syndrome in tree shrews [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(25): 3994-4000.
[3]	Liu Yulin, Li Guotai. Combined effects of hyperbaric oxygen, vibration training and astaxanthin on bone mineral density, glucose metabolism and oxidative stress in diabetic osteoporosis rats [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(20): 3117-3124.
[4]	Sun Weixing, Zhao Yongchao, Zhao Ranzun. Mesenchymal stem cell transplantation in the treatment of myocardial infarction: problems, crux and new breakthrough [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(19): 3103-3109.
[5]	Chen Xiao, Guo Zhi, Chen Lina, Liu Xuanyong, Zhang Yihuizhi, Li Xumian, Wang Yueqiao, Wei Liya, Xie Jing, Lin Li. Factors affecting the mobilization and collection of autologous peripheral blood hematopoietic stem cells [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(19): 2958-2962.
[6]	Zhang Chuanhui, Li Jianjun, Yang Jun. Effects of dynamic pressure on the proliferation and mechanical properties of rabbit adipose mesenchymal stem cells transfected with insulin-like growth factor-1 [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(13): 1982-1987.
[7]	Cao Linlin, Ding Kaiyang, Song Hao, Wu Guolin, Hu Maogui, Fan Dandan, Zhou Chenyang, Wang Cuicui, Feng Yuanyuan. Efficacy and influencing factors of autologous hematopoietic stem cell transplantation in the treatment of malignant lymphoma [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(13): 1993-1998.
[8]	Zhang Wenjian, Ma Lingfu, Wang Zhimin, Mo Wenjian, Zhou Ruiqing. Muscle mass evaluation and influencing factors of sarcopenia in allogeneic hematopoietic stem cell transplantation patients [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(13): 1999-2004.
[9]	Qian Nannan, Zhang Qian, Yang Rui, Ao Jun, Zhang Tao. Mesenchymal stem cells in the treatment of spinal cord injury: cell therapy and combination of new drugs and biomaterials [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(13): 2114-2120.
[10]	Guo Xuan, Xie Jun, Suo Jinrong, Li Yingrui, Huang Lei, Ma Munan, Li Jingjing, Fu Songtao. Transplantation of islet-like cells induced by human umbilical cord mesenchymal stem cells via different ways for the treatment of type 1 diabetic mice [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(1): 78-83.
[11]	Ruan Guangping, Yao Xiang, Cai Xuemin, Li Zian, Pang Rongqing, Pan Xinghua. Effect of umbilical cord mesenchymal stem cell transplantation for treating systemic lupus erythematosus in a tree shrew model [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(1): 90-95.
[12]	Zang Jing, Luan Zuo, Wang Qian, Yang Yinxiang, Wang Zhaoyan, Wu Youjia, Guo Aisong. Two kinds of stem cell nasal transplantation for treating white matter injury in premature rat infants [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(1): 101-107.
[13]	Jing Yucheng, Wang Le, Wang Xianyun, Wei Mei, Li Min, Ji Lishuang, Ma Fangfang, Liu Gang , Zheng Mingqi. Umbilical cord mesenchymal stem cell transplantation in the treatment of ischemic heart disease: a 3-year follow-up [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(1): 6-12.
[14]	Zhu Bingbing, He Haibin, Deng Jianghua, Wang Wenqiang, Mu Xiaoling. Human umbilical cord mesenchymal stem cells overexpressing interleukin 8 receptor inhibit inflammation and promote vascular repair [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(1): 61-66.
[15]	Chen Ganghong, Zeng Chaoming, Chen Ziming, Liao Junxing, Ma Yuanchen, Zheng Qiujian . Intra-articular injection of optimal concentration of bone marrow mesenchymal stem cells for treating rabbit cartilage defects [J]. Chinese Journal of Tissue Engineering Research, 2020, 24(7): 996-1001.